FLJ10490 Inhibitors
FLJ10490 Inhibitors encompass a group of chemical compounds that target various signaling pathways and cellular processes that could be involved in the functional regulation of FLJ10490. Staurosporine is known to inhibit a wide spectrum of kinases, and if FLJ10490 is a phospho-protein, its function could be diminished as a result of reduced phosphorylation. Similarly, both Wortmannin and LY294002 serve as PI3K inhibitors, which could lead to a decrease in AKT activation. If FLJ10490's stability or activity is dependent on PI3K/AKT signaling, inhibition of this pathway would result in a decrease in FLJ10490 function. The MAPK pathway, targeted by U0126 and PD98059, is another potential regulator of FLJ10490, and inhibition of MEK would prevent the activation of ERK, consequently reducing FLJ10490 activity if it lies downstream. SB203580 and SP600125 target the p38 MAPK and JNK pathways, respectively, and would inhibit FLJ10490 if it is modulated by these stress-response signaling cascades.
Rapamycin specifically inhibits mTOR, and if FLJ10490 is a protein whose function is regulated by mTOR signaling, the inhibition of this pathway would lead to a reduction in FLJ10490 activity. Cyclosporin A, through the inhibition of calcineurin, could decrease the dephosphorylation of proteins; if FLJ10490 requires dephosphorylation for activation, its function would be indirectly inhibited. Thapsigargin disrupts calcium homeostasis, which could impact FLJ10490 if its activity is calcium-dependent.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum protein kinase inhibitor that can inhibit multiple kinases that may phosphorylate FLJ10490, therefore potentially reducing FLJ10490 activation if it is regulated by phosphorylation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A phosphoinositide 3-kinase (PI3K) inhibitor that can downregulate PI3K/AKT signaling, which might be necessary for the stabilization and activity of FLJ10490 if it is part of a signaling cascade. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that can decrease AKT activation, potentially leading to reduced activity of downstream proteins including FLJ10490 if its activity is contingent upon this pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of MEK1/2, which in turn inhibits ERK1/2 phosphorylation; if FLJ10490 is a downstream effector of the MAPK pathway, its function would be indirectly reduced. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MEK that prevents the activation of MAPK/ERK, thereby potentially reducing the functional activity of FLJ10490 if it operates downstream of this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A specific inhibitor of p38 MAPK; if FLJ10490 is involved in the p38 MAPK stress response pathway, this compound would reduce its functional activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK); if FLJ10490's activity is modulated by JNK signaling, this would lead to decreased function of FLJ10490. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can suppress the mTORC1 complex, potentially affecting proteins involved in the downstream signaling; if FLJ10490 is mTOR-regulated, its function would be diminished. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that inhibits calcineurin; if FLJ10490 is regulated by dephosphorylation via calcineurin, its activity would be indirectly inhibited. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor that leads to increased cytosolic calcium levels; if FLJ10490's function depends on calcium homeostasis, this disruption could reduce its activity. | ||||||